新光药业
(300519)
| 流通市值：15.88亿 | | | 总市值：22.27亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 142,593,090.09 | 88,469,330.56 | 265,359,823.7 | 205,618,567.89 |
| 营业总成本 | 101,939,916.61 | 59,792,683.17 | 208,296,602.07 | 155,285,531.11 |
| 其他经营收益 | | | | |
| 营业利润 | 45,398,616.27 | 30,467,871.49 | 64,864,262.64 | 55,022,446.12 |
| 利润总额 | 45,456,188 | 30,467,871.49 | 63,427,072.98 | 53,571,739.38 |
| 净利润 | 39,712,072.46 | 26,367,975.34 | 54,211,458.52 | 45,336,178.34 |
| 每股收益 | | | | |
| 其他综合收益 | -866,110.88 | -122,750.41 | 67,953.34 | 80,363.36 |
| 综合收益总额 | 38,845,961.58 | 26,245,224.93 | 54,279,411.86 | 45,416,541.7 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 773,587,330.49 | 808,487,676.88 | 767,340,354.61 | 767,648,466.09 |
| 非流动资产: | | | | |
| 非流动资产合计 | 108,858,569.54 | 112,914,143.44 | 122,075,764.98 | 125,757,677.93 |
| 资产总计 | 882,445,900.03 | 921,401,820.32 | 889,416,119.59 | 893,406,144.02 |
| 流动负债: | | | | |
| 流动负债合计 | 46,155,849.58 | 49,365,199.47 | 44,709,675.9 | 57,243,393.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 7,256,847.41 | 7,604,154.46 | 7,895,202.23 | 8,214,379.61 |
| 负债合计 | 53,412,696.99 | 56,969,353.93 | 52,604,878.13 | 65,457,772.72 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 829,033,203.04 | 864,432,466.39 | 836,811,241.46 | 827,948,371.3 |
| 股东权益合计 | 829,033,203.04 | 864,432,466.39 | 836,811,241.46 | 827,948,371.3 |
| 负债和股东权益合计 | 882,445,900.03 | 921,401,820.32 | 889,416,119.59 | 893,406,144.02 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 144,142,560.78 | 95,596,532.26 | 282,831,674.07 | 216,677,397.85 |
| 经营活动现金流出小计 | 86,364,272.21 | 43,792,838.02 | 213,907,179.44 | 166,089,341.84 |
| 经营活动产生的现金流量净额 | 57,778,288.57 | 51,803,694.24 | 68,924,494.63 | 50,588,056.01 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 440,621,505.03 | 147,939,551.05 | 640,971,145.95 | 348,107,095.34 |
| 投资活动现金流出小计 | 430,211,346.75 | 90,053,746.75 | 853,475,750.9 | 563,480,119.27 |
| 投资活动产生的现金流量净额 | 10,410,158.28 | 57,885,804.3 | -212,504,604.95 | -215,373,023.93 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,000,000 | - | 1,000,000 | 1,000,000 |
| 筹资活动现金流出小计 | 49,000,000 | - | 49,000,000 | 49,000,000 |
| 筹资活动产生的现金流量净额 | -48,000,000 | - | -48,000,000 | -48,000,000 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 20,188,446.85 | 109,689,498.54 | -191,580,110.32 | -212,784,967.92 |
| 期末现金及现金等价物余额 | 332,024,461.99 | 421,525,513.68 | 311,836,015.14 | 290,631,157.54 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 20,188,446.85 | - | -191,580,110.32 | - |